As of January 2025, it is FDA-approved and may be helpful as a smoking cessation aid
JL: Conceptualization, Data curation, Supervision, Writing review & editing
Chewing tobacco effects, such as gum disease, tooth decay, and an increased risk of oral cancer, are well-documented concerns for users
(4) Notwithstanding paragraph (c)(3) of this section, for a Part B rebatable drug that was billed under a NOC code during the calendar quarter beginning July 1, 2021, or the third full calendar quarter after such drug's first marketed date, whichever is later, the payment amount benchmark quarter is the third full calendar quarter after the Part B rebatable drug is assigned a billing and payment code other than a NOC code
Within 1 to 2 years of quitting: Your risk of coronary heart disease is half that of someone still using tobacco